Brief: Betterlife Secures Mitacs Funding In Collaboration With Carleton University Research Team For Td-0148A Preclinical Depression Studies
24/06/2021 13:05
June 24 (Reuters) - BetterLife Pharma Inc BETR.CD :
* BETTERLIFE SECURES MITACS FUNDING IN COLLABORATION WITH
CARLETON
UNIVERSITY RESEARCH TEAM FOR TD-0148A PRECLINICAL DEPRESSION
STUDIES
Source text for Eikon: ID:nGNX1D87GP
Further company coverage: BETR.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BetterLife Pharma
See all newsBrief: Betterlife Pharma Provides Scientific Update On Neuroplastogenic Activity Of BETR-001
Brief: Betterlife Pharma Advanced In IND-enabling Studies For BETR-001
Brief: BetterLife Announces Closing Of $1.168 Million Convertible Debentures To Further Advance IND-Enabling Studies Of Its Non-Hallucinogenic LSD-Based Drug Candidate BETR-001
Brief: Omineca Announces $2 Mln Brokered Financing Of Flow-Through Units
Brief: Betterlife Announces Pricing Of Proposed Offering Of Units